CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Azithromycin 250 MGWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1098 Hydroxychloroquine 200 Mg Oral Tablet Wiki 0.71

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.06

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials


1 Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 Pneumonia: A Randomized,Open-label,Controlled Clinical Trial

This study investigates the efficay and tolerance of 5-days course of hydroxychloroquine or hydroxychloroquine and azithromycin of patients with COVID-19 infection. The investigators will undertake a randomized, double-blind, controlled Trial in the region of Sousse Tunisia

NCT04405921 SARS-CoV-2 Pneumonia COVID-19 Drug: Hydroxychloroquine 200 Mg Oral Tablet Drug: Azithromycin 250 MG
MeSH:Pneumonia
HPO:Pneumonia

Primary Outcomes

Description: Clinical recovery is defined as a complete resolution clinical signs appeared during the medical history and related to COVID-19.

Measure: Clinical recovery at day-14, from the start of treatment.

Time: 14 days

Secondary Outcomes

Description: RT-PCR will be realized in same laboratory

Measure: Viral Clearance via RT-PCR at day 5- 7-10 and day 14

Time: 5- 7-10 and day 14


Related HPO nodes (Using clinical trials)